Reflux after Intravitreal Injection of Bevacizumab

Ophthalmology

Volumn 115, Issue 7, 2008, Pages 1270-

  Boon, Camiel J F ^a   Crama, Niels ^a   Klevering, B Jeroen ^a   van Kuijk, Frederik J ^a   Hoyng, Carel B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; GENTAMICIN; MEPIVACAINE; OXYBUPROCAINE; POVIDONE IODINE;

ADULT; AGED; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LETTER; LIQUEFACTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RISK FACTOR; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VITREOUS BODY; VITREOUS BODY DETACHMENT;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 45849141271     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.02.021     Document Type: Letter

References (3)

1. Benz M.S., Albini T.A., Holz E.R., et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113 (2006) 1174-1178
2. Morlet N., and Young S.H. Prevention of intraocular pressure rise following intravitreal injection. Br J Ophthalmol 77 (1993) 572-573
3. Rodrigues E.B., Meyer C.H., Grumann Jr. A., et al. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 143 (2007) 1035-1037